SYBT
PTX

Stock Yards Bank & Trust’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Stock Yards Bank & Trust’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,017
Closed -$19K – 214
2016
Q3 		$19K Hold
3,017
– – ﹤0.01% 205
2016
Q2 		$14K Buy
+3,017
New +$19.7K ﹤0.01% 218

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stock Yards Bank & Trust's PTX Position: Q4 2016 in Review

Stock Yards Bank & Trust sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2016, closing a stake of 3,017 shares — an estimated $19K sold.

Stock Yards Bank & Trust first reported a position in PTX in Q2 2016 and held it in 2 quarters. The position peaked at $19K in Q3 2016. 34 funds tracked by Wall St. Rank hold PTX as of Q4 2016.

  • Stock Yards Bank & Trust reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
  • Stock Yards Bank & Trust sold 3,017 Pernix Therapeutics Holdings, Inc. shares in Q4 2016, an estimated $19K.
  • Stock Yards Bank & Trust first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2016 and held it in 2 quarters.
  • Stock Yards Bank & Trust's Pernix Therapeutics Holdings, Inc. position peaked at $19K in Q3 2016.
  • 34 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2016.

Based on Stock Yards Bank & Trust's 13F filing for Q4 2016, filed 11 Jan 2017.